Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences
暂无分享,去创建一个
Samuel I. Miller | L. Hoffman | E. Borenstein | H. Hayden | D. Raftery | M. Brittnacher | S. Heltshe | Eli J. Weiss | D. Leung | A. Eng | Kyle R. Hager | C. Pope | A. Vo | Elhanan Borenstein
[1] Elhanan Borenstein,et al. MetaLAFFA: a flexible, end-to-end, distributed computing-compatible metagenomic functional annotation pipeline , 2020, BMC Bioinformatics.
[2] W. D. de Vos,et al. Maternal Fecal Microbiota Transplantation in Cesarean-Born Infants Rapidly Restores Normal Gut Microbial Development: A Proof-of-Concept Study , 2020, Cell.
[3] Samuel I. Miller,et al. CFTR dysregulation drives active selection of the gut microbiome , 2020, PLoS pathogens.
[4] Samuel I. Miller,et al. Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure , 2019, Nature Medicine.
[5] K. Switkowski,et al. Timing of Complementary Feeding Introduction and Adiposity Throughout Childhood , 2019, Pediatrics.
[6] Bota Cui,et al. Rescue fecal microbiota transplantation for antibiotic-associated diarrhea in critically ill patients , 2019, Critical Care.
[7] H. Knutsen,et al. Appropriate age range for introduction of complementary feeding into an infant's diet , 2019, EFSA journal. European Food Safety Authority.
[8] H. Verkade,et al. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice , 2019, Cellular and molecular gastroenterology and hepatology.
[9] G. Dantas,et al. Metagenomic signatures of early life hospitalization and antibiotic treatment in the infant gut microbiota and resistome persist long after discharge , 2019, Nature Microbiology.
[10] D. Raftery,et al. Metabolomic Characterization of Human Model of Liver Rejection Identifies Aberrancies Linked to Cyclooxygenase (COX) and Nitric Oxide Synthase (NOS) , 2019, Annals of transplantation.
[11] H. Verkade,et al. Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosis. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[12] F. De Filippis,et al. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype , 2018, PloS one.
[13] G. Bergström,et al. Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1 , 2018, Cell.
[14] R. Gibbs,et al. Temporal development of the gut microbiome in early childhood from the TEDDY study , 2018, Nature.
[15] E. Robilotti,et al. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant , 2018, Science Translational Medicine.
[16] E. Borenstein,et al. Taxa-function robustness in microbial communities , 2018, Microbiome.
[17] C. Y. Ooi,et al. Probiotics for people with cystic fibrosis. , 2018, The Cochrane database of systematic reviews.
[18] F. Turroni,et al. Glycan Utilization and Cross-Feeding Activities by Bifidobacteria. , 2017, Trends in microbiology.
[19] J. Casadesús,et al. Interactions between Bacteria and Bile Salts in the Gastrointestinal and Hepatobiliary Tracts , 2017, Front. Med..
[20] Aaron M. Walsh,et al. A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis , 2017, Scientific Reports.
[21] B. Ramsey,et al. Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life , 2017, JAMA pediatrics.
[22] K. Tomizawa,et al. Synthesis of l‐cysteine derivatives containing stable sulfur isotopes and application of this synthesis to reactive sulfur metabolome , 2017, Free radical biology & medicine.
[23] R. Weinstein,et al. Comparison of stool versus rectal swab samples and storage conditions on bacterial community profiles , 2017, BMC Microbiology.
[24] N. Simmonds,et al. Clostridium difficile and cystic fibrosis: management strategies and the role of faecal transplantation. , 2017, Paediatric respiratory reviews.
[25] Elhanan Borenstein,et al. Systematic Characterization and Analysis of the Taxonomic Drivers of Functional Shifts in the Human Microbiome. , 2017, Cell host & microbe.
[26] E. Borenstein,et al. Revised computational metagenomic processing uncovers hidden and biologically meaningful functional variation in the human microbiome , 2017, Microbiome.
[27] P. Palange,et al. Cystic fibrosis , 2016, The Lancet.
[28] W. Garrett,et al. Gut microbiota induce IGF-1 and promote bone formation and growth , 2016, Proceedings of the National Academy of Sciences.
[29] S. Turroni,et al. Gut Bifidobacteria Populations in Human Health and Aging , 2016, Front. Microbiol..
[30] Hanns-Ulrich Marschall,et al. Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. , 2016, Cell metabolism.
[31] T. Thomas,et al. Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis , 2016, Scientific Reports.
[32] M. Ferrer,et al. Functional Redundancy-Induced Stability of Gut Microbiota Subjected to Disturbance. , 2016, Trends in microbiology.
[33] M. Xian,et al. The metabolism and biotechnological application of betaine in microorganism , 2016, Applied Microbiology and Biotechnology.
[34] Samuel I. Miller,et al. Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis , 2016, Scientific Reports.
[35] Casey M. Theriot,et al. Metabolic Model-Based Integration of Microbiome Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological and Metabolic Variation , 2016, mSystems.
[36] J. Choo,et al. Sample storage conditions significantly influence faecal microbiome profiles , 2015, Scientific Reports.
[37] Minoru Kanehisa,et al. KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..
[38] P. Savelkoul,et al. The Effect of Sampling and Storage on the Fecal Microbiota Composition in Healthy and Diseased Subjects , 2015, PloS one.
[39] V. Tremaroli,et al. Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. , 2015, Cell host & microbe.
[40] W. Bernhard,et al. Plasma Phosphatidylcholine Alterations in Cystic Fibrosis Patients: Impaired Metabolism and Correlation with Lung Function and Inflammation , 2015, Cellular Physiology and Biochemistry.
[41] Elhanan Borenstein,et al. Extensive Strain-Level Copy-Number Variation across Human Gut Microbiome Species , 2015, Cell.
[42] Chao Xie,et al. Fast and sensitive protein alignment using DIAMOND , 2014, Nature Methods.
[43] Elhanan Borenstein,et al. MUSiCC: a marker genes based framework for metagenomic normalization and accurate profiling of gene abundances in the microbiome , 2014, bioRxiv.
[44] Daniel Raftery,et al. Colorectal cancer detection using targeted serum metabolic profiling. , 2014, Journal of proteome research.
[45] Qunyuan Zhang,et al. Persistent Gut Microbiota Immaturity in Malnourished Bangladeshi Children , 2014, Nature.
[46] P. Hylemon,et al. Bile acids and the gut microbiome , 2014, Current opinion in gastroenterology.
[47] Samuel I. Miller,et al. Gastrointestinal pathology in juvenile and adult CFTR-knockout ferrets. , 2014, The American journal of pathology.
[48] Samuel I. Miller,et al. Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis. , 2014, Clinical Infectious Diseases.
[49] D. Borowitz,et al. Intestinal complications of cystic fibrosis , 2013, Current opinion in pulmonary medicine.
[50] C. Buffie,et al. Microbiota-mediated colonization resistance against intestinal pathogens , 2013, Nature Reviews Immunology.
[51] R. D. De Lisle,et al. The cystic fibrosis intestine. , 2013, Cold Spring Harbor perspectives in medicine.
[52] P. Edwards,et al. Pleiotropic roles of bile acids in metabolism. , 2013, Cell metabolism.
[53] Maarten Bekaert,et al. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[54] M. Lucarelli,et al. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients , 2013, PloS one.
[55] George C. Runger,et al. Gene selection with guided regularized random forest , 2012, Pattern Recognit..
[56] R. Curi,et al. Regulation of Inflammation by Short Chain Fatty Acids , 2011, Nutrients.
[57] M. Rosenfeld,et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. , 2009, The Journal of pediatrics.
[58] S. Zeisel,et al. Choline: an essential nutrient for public health. , 2009, Nutrition reviews.
[59] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.
[60] Ting Wang,et al. The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[61] Zhongtang Yu,et al. Improved extraction of PCR-quality community DNA from digesta and fecal samples. , 2004, BioTechniques.
[62] F. Guarner,et al. Gut flora in health and disease , 2003, The Lancet.
[63] L. Breiman. Random Forests , 2001, Machine Learning.
[64] J. Skinner,et al. Transitions in infant feeding during the first year of life. , 1997, Journal of the American College of Nutrition.
[65] H. Fenlon,et al. Intestinal bile acid malabsorption in cystic fibrosis. , 1993, Gut.
[66] G. Davidson,et al. In Vivo Bile Acid Uptake from Terminal Ileum in Cystic Fibrosis , 1988, Pediatric Research.
[67] H. Sakata,et al. The effect of antimicrobial agents on fecal flora of children , 1986, Antimicrobial Agents and Chemotherapy.
[68] H. Iwahashi,et al. Enzymatic proof for the identity of the S-sulfocysteine synthase and cysteine synthase B of Salmonella typhimurium , 1984, Journal of bacteriology.